Paclitaxel-Coated Balloon Superior for In-Stent Restenosis
The drug-coated balloon was superior to an uncoated balloon in patients undergoing PCI for in-stent restenosis, setting the stage for FDA approval.
The drug-coated balloon was superior to an uncoated balloon in patients undergoing PCI for in-stent restenosis, setting the stage for FDA approval.
Either intervention alone improved health in a small trial, but the best results occurred when the two were used together.
The American College of Cardiology, a 49,000-member nonprofit medical society, is dedicated to enhancing the lives of cardiovascular patients through continuous quality improvement, patient-centered care,…
Despite improved survival rates and guideline recommendations, many eligible patients with metastatic Merkel cell carcinoma are not receiving immunotherapy.
Cisplatin is lifesaving for many people with cancer, but acute kidney injury is a common and serious toxicity — can a tool identify those at…
Objective The management of blood pressure (BP) in acute ischaemic stroke remains a subject of controversy. This investigation aimed to explore the relationship between 24-hour…
The VICTORION-INIATATE study demonstrated that initiating inclisiran, a highly potent lipid-lowering therapy, upon failure to achieve lipid targets with statins, yielded superior outcomes compared to…
With the approval of mavacamten, patients with hypertrophic cardiomyopathy now have more options, Steve Ommen says.
The American Heart Association’s new Workforce Well-being Scorecard is designed to help employers evaluate the culture of health and well-being within their workforces to identify…
Physician assistants (PAs) seem increasingly dissatisfied with their compensation, even though it rose last year. Gender and age made a difference, with male and older…